NewsAASLD Opens Call for Applications for Sites to Participate in TARGET-LD and the Cirrhosis Quality Collaborative (CQC Data Registry)Read more →Read more →
NewsThe Liver Meeting 2024 Research: Cirrhosis Presentation by Arun J. Sanyal, MBBS, MDRead more →Read more →
NewsTarget RWE Highlights GLP-1 Receptor Agonists in Patients with Metabolic Dysfunction Associated Steatotic Liver Disease at The Liver Meeting 2024Read more →Read more →
AASLD Opens Call for Applications for Sites to Participate in TARGET-LD and the Cirrhosis Quality Collaborative (CQC Data Registry)Read more →
Target RWE Highlights GLP-1 Receptor Agonists in Patients with Metabolic Dysfunction Associated Steatotic Liver Disease at The Liver Meeting 2024Read more →
Target RWE Unveils Latest Developments in TARGET-Liver Disease and Cirrhosis Quality Collaborative Partnership with the American Association for the Study of Liver DiseasesRead more →
World's Largest Liver Disease-Focused Registry Surpasses 400,000 Patient Enrollment MilestoneRead more →
Target RWE Launches Novel Precision Medicine Platform to Undertake Growing Unmet Medical Needs in Liver Disease, Gastroenterology, and Immune-mediated Inflammatory ConditionsRead more →
Target RWE Releases Important Updates on the Cirrhosis Quality Collaborative/TARGET-Liver Disease Partnership with the American Association for the Study of Liver DiseasesRead more →
Target RWE and the American Association for the Study of Liver Diseases Announce Research Agreement for Cirrhosis Quality CollaborativeRead more →
